What is Progeria?

1 in ~ 20Mln

The number of children affected by Progeria worldwide

14 - 15 years

The average lifespan of patients without intervention

1 in ~ 6Bln

The number of point mutations enough to cause Progeria

1
DNA mutation
LMNA point mutation causing Progeria
created with BioRender.com

Point mutation in LMNA gene leads to incorrect post-translational modifications. Progerin is then produced instead of lamin A

2
Progerin
accumulation
Progerin accumulates at the nuclear envelope
created with BioRender.com

Progerin retains a farnesyl group and anchors to the nuclear envelope, escaping normal processing and turnover

3
Cellular
consequences
Nuclear shape defects and cellular stress
created with BioRender.com

Nuclear shape defects, genome instability, altered gene expression and impaired repair accelerate cellular aging

4
Clinical symptoms
Clinical symptoms of Progeria
created with BioRender.com

Growth delay, alopecia, lipodystrophy, bone fragility and cardiovascular disease (leading cause of premature mortality)

Why This Research Matters

By studying the mechanisms behind accelerated aging in rare diseases like Progeria, we not only aim to benefit millions facing age-related diseases, but also bring much-needed attention from the broader research community to these often-overlooked conditions. We got inspired by Sammy Basso, our colleague at University of Padova, who not only lived with Progeria but also conducted research to help others.

"Rather than focusing on the limits that Progeria imposes, I prefer to think about the many things in which I can make a difference."

-Sammy Basso

Our Solution

We aim to utilize the Ring Bait System, a recently developed technique for inducing proximity-dependent protein degradation. This method relies on recruiting a protein of interest to the proteasome through a custom-designed interaction with a bait protein fused to a degradation domain.

Ring Bait flow
created with BioRender.com

3-Pillar Strategy

We integrate computational biology, model organisms and mammalian systems for comprehensive therapeutic development.

1
Computational Biology

In silico prediction of progerin interactor structure and estimation of their binding affinity, along with in vitro validation.

Explore
2
Yeast Model Testing

Testing peptide-progerin interaction in S. cerevisiae through Yeast-2-Hybrid assay, building a model for Progeria studies.

Explore
3
Mammalian Cells Validation

Ring Bait System testing in human cell cultures to validate possible future therapeutic approaches.

Explore

Beyond Progeria

While our primary focus is developing treatments for Progeria, this research contributes to the broader understanding of cellular aging mechanisms that affect us all.

Cellular Repair Mechanisms

Understanding how cells respond to accelerated aging could inform treatments for age-related diseases like cardiovascular and neurodegenerative ones.

Therapeutic Development

Our multi-pillars approach creates a robust pipeline for testing anti-aging therapies across different in vitro and in vivo models.

Scientific
Collaboration

This work builds bridges between several fields such as computational biology, genetics and clinical research, fostering interdisciplinary innovation.

Like Sammy Basso, who approached life's challenges with curiosity and determination, we approach this research with the belief that every scientific question is an opportunity to make a difference. Our work embodies his spirit of turning obstacles into stepping stones for others.


E.A.S.Y. - Easy Accessible Science for You

As part of our commitment to rare diseases research, we are launching the E.A.S.Y. project - Easy Accessible Science for You. This initiative is dedicated to developing innovative tools that simplify scientific literature for patients with Specific Learning Disorders (SLD). By making complex research more understandable and accessible, we aim to shine a light on often-overlooked communities, ensuring that minorities receive the attention and support they deserve.
E.A.S.Y. embodies our belief that scientific progress should benefit everyone.

Phase 1, May '25 - Jul '25

Preliminary Survey

Anonymous survey to collect people experiences about backgrounds, reading habits, obstacles encountered in understanding texts and strategies that help them along the way.

Phase 2, Aug '25

Article Simplification

Based on the survey results, create simplified versions of different scientific articles.

Phase 3, Sep '25 - Oct '25

Experiments & Interviews

Test the simplified articles with target users and gather feedback.

Phase 4, 28 - 31 Oct '25

Results Release

Present our work at the 2025 iGEM Grand Jamboree.

Phase 5, Nov '25 - Dec '25

Publishing & Tool Development

Writing a scientific article to publish our findings, along with the design and build of an AI-based tool that simplifies scientific papers according to the needs of the user.